Posts
https://myoncopath.com/wp-content/uploads/2019/03/Screen-Shot-2019-03-06-at-11.52.12-AM.png
295
611
hwetzel
https://myoncopath.com/wp-content/uploads/2017/07/myoncopath_test_3.svg
hwetzel2019-03-06 16:55:032019-05-16 19:22:45Vitrakvi approved for NTRK+ cancers | MyOncoPath
https://myoncopath.com/wp-content/uploads/2018/04/Next-Generation-Sequencing-Genetic-Tests.jpg
3162
4743
Ben Harmssen
https://myoncopath.com/wp-content/uploads/2017/07/myoncopath_test_3.svg
Ben Harmssen2018-04-26 03:18:212019-05-16 19:28:27FDA Finalizes Next Generation Sequencing Genetic Tests to Accelerate Reliable Development
https://myoncopath.com/wp-content/uploads/2018/04/Genetic-Counselor-Ordering-Companion-Diagnostic-Test.jpg
4016
6016
Ben Harmssen
https://myoncopath.com/wp-content/uploads/2017/07/myoncopath_test_3.svg
Ben Harmssen2018-04-03 02:44:382019-05-16 19:29:40FoundationOne CDx Comprehensive Genomic Profiling for Solid Tumors Now Commercially Available
https://myoncopath.com/wp-content/uploads/2017/12/PD-1-PD-L1-Immune-checkpoint-protein.jpg
2684
4000
Ben Harmssen
https://myoncopath.com/wp-content/uploads/2017/07/myoncopath_test_3.svg
Ben Harmssen2017-12-15 19:50:422019-05-16 19:32:58Keytruda Immunotherapy FDA Approval - Cancer Treatment for Tumors with Specific Genetic Markers
https://myoncopath.com/wp-content/uploads/2017/12/Targeted-Therapy-Genetic-Testing-in-Lab.jpg
3744
5616
Ben Harmssen
https://myoncopath.com/wp-content/uploads/2017/07/myoncopath_test_3.svg
Ben Harmssen2017-12-13 19:20:092019-05-16 19:35:09FDA announces approval, CMS proposes coverage of first breakthrough-designated test to detect extensive number of cancer biomarkers
https://myoncopath.com/wp-content/uploads/2017/10/Genetic-Counseling-Telemedicine-Clinic-Accessible-in-Most-States.png
382
597
Ben Harmssen
https://myoncopath.com/wp-content/uploads/2017/07/myoncopath_test_3.svg
Ben Harmssen2017-10-24 16:05:022019-05-16 19:39:09Benefits of Telemedicine in Genetic Counseling for Cancer Patients & Providers